Long-Term Risperidone Treatment Induces Visceral Adiposity Associated with Hepatic Steatosis in Mice: A Magnetic Resonance Approach
Although atypical antipsychotic drugs (APDs) have led to significant advances in the treatment of psychotic disorders, they still induce metabolic disturbances. We aimed at characterizing the metabolic consequences of a risperidone treatment and at establishing a link with noninvasive MR markers, in...
Main Authors: | Florent Auger, Patrick Duriez, Françoise Martin-Nizard, Nicolas Durieux, Régis Bordet, Olivier Pétrault |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Schizophrenia Research and Treatment |
Online Access: | http://dx.doi.org/10.1155/2014/429291 |
Similar Items
-
Visceral adiposity links cerebrovascular dysfunction to cognitive impairment in middle-aged mice
by: Olivier Pétrault, et al.
Published: (2019-10-01) -
Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by 18F-FDG PET/CT
by: Lijun Hu, et al.
Published: (2020-05-01) -
Interleukin-6 mediated exercise-induced alleviation of adiposity and hepatic steatosis in mice
by: Long Li, et al.
Published: (2021-08-01) -
The role of ultrasonography in the measurement of subcutaneous and visceral fat and its correlation with hepatic steatosis
by: Roberto Velloso Eifler
Published: (2013-09-01) -
The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter.
by: Hye Won Lee, et al.
Published: (2017-01-01)